Confidential Agreements. Each Party has employment agreements with its respective employees and representatives having confidentiality and nonuse commitments consistent with their obligations hereunder and will require all of their sub-licensees hereunder, consultants, agents or others who have access to any of such information to execute similar confidentiality agreements covering all Confidential Information subject to Article 4 and will exercise its reasonable best efforts to obtain compliance therewith.
Confidential Agreements. Save as disclosed, the Company has not and none of the Sellers nor any of their connected persons have entered into any confidentiality or other agreement or is subject to any duty which restricts the free use or disclosure of any information used in the business of the Company and there is no breach of any such agreement or duty.
Confidential Agreements. Save as disclosed, the Company has not and none of the Vendors nor any of their Related Persons has entered into any confidentiality or other agreement or is subject to any duty which restricts the free use or disclosure of any information used in the business of the Company and so far as the Vendors are aware there is no breach of any such agreement or duty.
Confidential Agreements. Save as disclosed, so far as Xxxxxx is aware no Group Company nor any Vendor in relation to the Asset Businesses nor any member of the Xxxxxx Group has entered into any confidentiality agreement or arrangement otherwise than in the ordinary course of business or save in the ordinary course of business is subject to any duty which materially restricts the free use or disclosure of any information used in the Business and there is no material breach of any such agreement or duty.
Confidential Agreements. Seller and Target will use commercially reasonable efforts to obtain such consents as may be reasonably necessary to disclose to Buyer any contract or agreement not previously disclosed to Buyer due to the confidentiality obligations of Seller and Target (as described in Section 3.32(b)).
Confidential Agreements. (a) Save as disclosed, neither the Vendors nor any of their Related Persons nor the Company has entered into any confidentiality or other agreement or is subject to any duty which restricts the free use or disclosure of any information used in the business of the Company and there is no breach of any such agreement or duty.
Confidential Agreements. ANDA and WSCC must keep all technical documents concerning the products that WSCC has developed secret during the development, and also for a minimum period of three years after the development contract is completed. Neither ANDA nor WSCC can provide the products information to any third part without the permission of the other party. The exception to this would be if a third party subsequently acquires either party. In this case, the intellectual property and confidentiality shall be transferred to the acquiring party. Schedule
Confidential Agreements. So far as the Warrantor is aware none of the operations of the Business involve the unauthorised use of confidential information disclosed in circumstances which might entitle a third party to make a claim against the operator of the Business.
Confidential Agreements. Each of the Lead Arranger, the Administrative Agent and the Lenders agrees to keep confidential all non-public information provided to it by any Obligor or their respective Subsidiaries or Affiliates pursuant to this Agreement; provided that nothing herein shall prevent the Lead Arranger, the Administrative Agent or any Lender from disclosing any such information (a) to the Lead Arranger, the Administrative Agent, any other Lender or any Affiliate of any thereof, so long as such Affiliate is informed of the confidential nature of the information and instructed to keep such information confidential pursuant to this Section 10.20, (b) to any Participant or assignee of the Loans (each, a “Transferee”) or prospective Transferee, so long as such Transferee is informed of the confidential nature of such information and instructed to keep such information confidential pursuant to this Section 10.20, (c) to any of its employees, directors, agents, attorneys, accountants, and other professional advisors, including, without limitation, the Financial Advisor, so long as such Person is informed of the confidential nature of the information and instructed to keep such information confidential pursuant to this Section 10.20, (d) to any financial institution that is a direct or indirect contractual counterparty in swap agreements or such contractual counterparty’s professional advisor (so long as such contractual counterparty or professional advisor to such contractual counterparty is informed of the confidential nature of the information and instructed to keep such information confidential pursuant to this Section 10.20), (e) upon the request or demand of any Governmental Authority having jurisdiction over it, (f) in response to any order of any court or other Governmental Authority or as may otherwise be required pursuant to any requirement of law, (g) if requested or required to do so in connection with any litigation or similar proceeding, (h) that has been publicly disclosed other than in breach of this Section 10.20, (i) to the National Association of Insurance Commissioners or any similar organization or any nationally recognized rating agency that requires access to information about a Lender’s investment portfolio in connection with ratings issued with respect to such Lender (j) in connection with the exercise of any remedy hereunder or under any other Loan Document, (k) with the Borrower’s consent or (l) that becomes available to the Lead Arranger, the Administ...
Confidential Agreements. 13 6. SUPPLY OF MODEX LICENSED PRODUCT................................................... 13 6.1. General....................................................................... 13 6.2. Supply of Modex Licensed Products for Clinical Trials......................... 13 6.3. Supply of Modex Licensed Products for Commercial Sale......................... 14 6.6. Exercise by Modex of Rights to Manufacture or Have Manufactured Modex Licensed Products........................................................................... 16 6.6.1 CTI's Failure to Perform..................................................... 16 6.6.2 Modex's Decision to Manufacture.............................................. 17 6.6.3 Modex's Rights to Manufacture Where Transfer Price Exceeds [***] of Net Sales.............................................................................. 17 7.
